🔴 Devonian Health Group is trading 21% down today on NYSE listing plans and public offering dilution

Devonian Health Group is trading at $8.00 (21% down) as investors react to the company's U.S. listing strategy and associated capital restructuring.

• The decline follows the announcement of a planned NYSE American listing and a concurrent underwritten public offering.
• A major share consolidation is creating significant volatility and uncertainty regarding potential dilution and future valuation.
• The move marks a sharp reversal from late-July gains that were initially driven by optimism over the company's U.S. market expansion.